Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation
Figure 6.Schematic depiction illustrates that VCP20 targeting VCP is a promising agent for inhibiting cellular proliferation and improving bone marrow microenvironment in MM.